Trial
NCT03367754
A Single Dose of Pembrolizumab in HIV-Infected People
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators
National Institutes of Health Clinical Center (CC)
Condition
Human Immunodeficiency Virus
Intervention
Placebo
Why stopped
Difficulty with subject recruitment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-01-17